Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pregnitude is a non-prescription dietary supplement formulated to support women's reproductive health, ovulatory function, and egg quality. It is a fixed-dose combination of myo-inositol (2000 mg) and folic acid (200 mcg) delivered as an oral powder. Myo-inositol, a naturally occurring substance belonging to the vitamin B complex group, helps improve insulin sensitivity and supports ovarian function, particularly in women with polycystic ovary syndrome (PCOS). Folic acid, a synthetic form of folate (vitamin B9), is essential for cell division, DNA synthesis, and fetal development, helping to prevent neural tube defects. Together, these ingredients work synergistically to promote regular menstrual cycles and enhance fertility in women trying to conceive.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pregnitude.